This hypothesis proposes that both phenotypes are the result of a genetic predisposition for reduced insulin secretion and action leading to decreased growth in fetal life and a decreased capacity to secrete and respond to insulin and, therefore, higher T2D risk [7,8]. Here, INS is linked to type 2 diabetes mellitus.